Previous close | 7.86 |
Open | 7.04 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 6.95 - 7.10 |
52-week range | 4.12 - 10.40 |
Volume | |
Avg. volume | 4,223 |
Market cap | 936,864 |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
MILAN, April 08, 2024--Newron presents existing evenamide study 014/015 data and future clinical development outlook for evenamide at 2024 SIRS Congress in Florence, Italy
MILAN, March 19, 2024--Newron Pharmaceuticals announces 2023 year-end financial results and provides 2024 business outlook.
MILAN, March 15, 2024--Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement